Enesi Pharma’s ImplaVax® Solid-Dose and Needle-Free Vaccination Platform Wins Best New Vaccine Technology/ Platform Award at the World Vaccine Congress

OXFORD, UK – 1 October 2020 – Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, is delighted to announce that ImplaVax® has won the ‘Best New Vaccine Technology/Platform Award’ at the World Vaccine Congress Washington Virtual annual event (28 September – 1 October 2020). The Vaccine Industry Excellence (ViE) Awards honour and recognise the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry and are a highlight of the World Vaccine Congress.

The World Vaccine Congress is the leading forum for the presentation and discussion of cutting-edge research and technology, and how these efforts can be integrated with pharma, biotech, academia and government to bring and produce better vaccines to the market in a sustainable, added-value fashion, while maximising impact, reach and equitable access worldwide.

Commenting on the award, David Hipkiss, Enesi Pharma CEO, said:

“We are delighted to win the Best New Vaccine Technology/Platform category at such a prestigious global vaccine event. It is particularly gratifying to win such an award at this time when innovation in vaccine development is so high on the public health agenda because of the Covid-19 pandemic. This award recognises the outstanding efforts and progress of the Enesi team in applying and leveraging our unique unit solid dose and needle-free ImplaVax® vaccination technology to multiple targets, indications, populations and geographies over the last three years and particularly so over the last 12 months as we strive in our goal to make a material and lasting impact on global health.”

 Mr Hipkiss will give a presentation today entitled ‘ImplaVax® – A World-Leading Next-Generation Vaccination Platform’ as part of the Bioprocessing and Manufacture channel at the World Vaccine Congress. The presentation will be streamed live at 15:45hrs EST (20:45hrs BST).